224 related articles for article (PubMed ID: 36978187)
1. Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia.
Fang K; Sun M; Leng Z; Chu Y; Zhao Z; Li Z; Zhang Y; Xu A; Zhang Z; Zhang L; Chen T; Xu M
J Exp Clin Cancer Res; 2023 Mar; 42(1):73. PubMed ID: 36978187
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
Cheng J; Zhang R; Yan M; Li Y
BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
[TBL] [Abstract][Full Text] [Related]
3. Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis.
Chang N; Ge N; Zhao Y; Yang L; Qin W; Cui Y
J Clin Lab Anal; 2022 May; 36(5):e24304. PubMed ID: 35312115
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2.
Zhang Z; Xiong R; Li C; Xu M; Guo M
Acta Biochim Biophys Sin (Shanghai); 2019 Aug; 51(8):826-833. PubMed ID: 31287493
[TBL] [Abstract][Full Text] [Related]
6. Circ_0109291 Promotes Cisplatin Resistance of Oral Squamous Cell Carcinoma by Sponging miR-188-3p to Increase
Gao F; Han J; Wang Y; Jia L; Luo W; Zeng Y
Cancer Biother Radiopharm; 2022 May; 37(4):233-245. PubMed ID: 32758011
[No Abstract] [Full Text] [Related]
7. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis.
Wang J; Jia J; Zhou L
Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433
[TBL] [Abstract][Full Text] [Related]
8. CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas.
Fang J; Ma Y; Li Y; Li J; Zhang X; Han X; Ma S; Guan F
Mol Carcinog; 2022 Nov; 61(11):1043-1055. PubMed ID: 36102200
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10.
Chen F; Xu B; Li J; Yang X; Gu J; Yao X; Sun X
J Exp Clin Cancer Res; 2021 Jan; 40(1):38. PubMed ID: 33485367
[TBL] [Abstract][Full Text] [Related]
10. CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis.
Mohapatra P; Shriwas O; Mohanty S; Ghosh A; Smita S; Kaushik SR; Arya R; Rath R; Das Majumdar SK; Muduly DK; Raghav SK; Nanda RK; Dash R
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434185
[TBL] [Abstract][Full Text] [Related]
11. GAS5 alleviates cisplatin drug resistance in oral squamous cell carcinoma by sponging miR-196a.
Yuan X; Jing Y; Guang M; Zhu J; Wang J; Wang Y; Zhang Y
J Int Med Res; 2022 Oct; 50(10):3000605221132456. PubMed ID: 36310502
[TBL] [Abstract][Full Text] [Related]
12. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
[TBL] [Abstract][Full Text] [Related]
13. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.
Wang T; Ge G; Ding Y; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Chin Med J (Engl); 2014; 127(12):2357-62. PubMed ID: 24931256
[TBL] [Abstract][Full Text] [Related]
14. IGF1R-phosphorylated PYCR1 facilitates ELK4 transcriptional activity and sustains tumor growth under hypoxia.
Zheng K; Sha N; Hou G; Leng Z; Zhao Q; Zhang L; He L; Xu M; Jiang Y; Chen T
Nat Commun; 2023 Sep; 14(1):6117. PubMed ID: 37777542
[TBL] [Abstract][Full Text] [Related]
15. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
16. MS-275 combined with cisplatin exerts synergistic antitumor effects in human esophageal squamous cell carcinoma cells.
Liu T; Guan F; Wang Y; Zhang Z; Li Y; Cui Y; Li Z; Liu H; Zhang Y; Wang Y; Ma S
Toxicol Appl Pharmacol; 2020 May; 395():114971. PubMed ID: 32217144
[TBL] [Abstract][Full Text] [Related]
17. PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation.
Zhao Y; Lu Q; Li C; Wang X; Jiang L; Huang L; Wang C; Chen H
Cell Death Dis; 2019 May; 10(5):359. PubMed ID: 31043582
[TBL] [Abstract][Full Text] [Related]
18. FOXO3a-regulated arginine metabolic plasticity adaptively promotes esophageal cancer proliferation and metastasis.
Sun W; Kou H; Fang Y; Xu F; Xu Z; Wang X; Yin R; Zhang Q; Jiang Q; Xu Y
Oncogene; 2024 Jan; 43(3):216-223. PubMed ID: 38049565
[TBL] [Abstract][Full Text] [Related]
19. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L
Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy.
McAlpine JA; Lu HT; Wu KC; Knowles SK; Thomson JA
BMC Cancer; 2014 Aug; 14():621. PubMed ID: 25164070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]